Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › VA › Roanoke › NPI 1033102942
Hospital

Carilion Medical Center

Carilion Medical Center was paid $124.86M by Medicaid between Jan 2018 and Dec 2024, across 589 billing codes. Its largest line is 99284, emergency room visit (serious) — 8.3% of everything it billed.

33Billing provider infoCARILION MEDICAL CENTER
ROANOKE, VA 24014
33aNPI1033102942assigned 08/25/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$124.86M
24GClaims2,897,971
24DCodes billed589
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Virginia

Rank by total paid#1 of 80
Median peer was paid$14.69M
This provider vs. median8.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official PRESCOTT, ELEANOR controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018314,402$10.93M
2019458,167$16.83M
2020400,141$16.07M
2021487,294$18.89M
2022421,483$19.81M
2023455,315$22.67M
2024incomplete361,169$19.67M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 8.3% 58,517 50,300 $10.30M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 8.2% 58,239 51,427 $10.24M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.8% 47,933 40,851 $8.45M
96361 Intravenous infusion, hydration; each additional hour 5.8% 24,706 20,267 $7.22M
41899 Unlisted procedure, dentoalveolar structures 3.4% 3,373 2,866 $4.22M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2.5% 5,709 5,310 $3.17M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.2% 13,158 12,025 $2.79M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.1% 49,702 17,080 $2.66M
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.0% 15,289 13,826 $2.50M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.9% 7,245 6,724 $2.31M
59899 1.8% 2,669 2,141 $2.27M
70450 Computed tomography, head or brain; without contrast material 1.8% 13,576 12,116 $2.24M
577 more codes
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.8% 18,536 $2.24M
64493 1.5% 1,969 $1.84M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 1.4% 5,390 $1.81M
77386 1.3% 3,309 $1.68M
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.3% 5,872 $1.59M
99213 Doctor's office visit, returning patient (routine) 1.3% 10,641 $1.58M
99220 1.1% 28,940 $1.38M
64483 1.1% 1,826 $1.37M
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.0% 20,566 $1.31M
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 1.0% 2,016 $1.28M
95810 Polysomnography; sleep staging with 4 or more additional parameters 1.0% 2,040 $1.27M
62323 1.0% 2,528 $1.27M
78815 Positron emission tomography (PET) for limited area imaging 1.0% 1,612 $1.26M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 16,090 $1.25M
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 2,236 $1.22M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 8,853 $1.21M
71275 Computed tomographic angiography, chest, with contrast material <1% 5,911 $1.06M
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 9,660 $944K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 64,564 $918K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 19,394 $908K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 633 $884K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 9,586 $872K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 1,395 $871K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 3,855 $797K
97161 <1% 6,204 $796K
97162 <1% 6,997 $709K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 3,364 $695K
96415 <1% 2,278 $695K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 3,701 $686K
99214 Doctor's office visit, returning patient (more involved) <1% 4,627 $671K
64635 <1% 895 $641K
59025 Fetal non-stress test <1% 3,138 $627K
62321 <1% 1,156 $613K
76830 Ultrasound, transvaginal <1% 5,409 $590K
43235 <1% 1,067 $577K
95806 <1% 1,078 $577K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 4,080 $572K
70551 Magnetic resonance imaging, brain; without contrast material <1% 2,419 $555K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 7,243 $534K
97802 <1% 5,594 $504K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 4,631 $496K
72141 <1% 2,522 $468K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 2,001 $448K
77067 Screening mammography, bilateral, including computer-aided detection <1% 7,972 $447K
74183 <1% 1,496 $433K
76642 <1% 4,020 $431K
70496 <1% 1,794 $424K
95811 <1% 792 $407K
71046 Radiologic examination, chest; 2 views <1% 17,402 $404K
47563 <1% 115 $400K
93971 <1% 3,764 $389K
97803 <1% 4,210 $387K
92523 <1% 2,653 $366K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 2,498 $342K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 3,632 $340K
80053 Comprehensive metabolic panel <1% 71,432 $333K
76770 <1% 2,255 $317K
93017 <1% 2,741 $305K
64494 <1% 2,016 $294K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 6,198 $294K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 2,744 $290K
93308 <1% 1,041 $289K
36430 <1% 1,636 $286K
99215 Doctor's office visit, returning patient (complex) <1% 1,215 $276K
77412 <1% 485 $272K
74174 <1% 1,250 $272K
74018 <1% 9,651 $269K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 5,466 $254K
Q5103 Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg <1% 257 $248K
76536 <1% 2,035 $242K
99234 <1% 11,720 $241K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 366 $237K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 63,165 $237K
97166 <1% 3,230 $233K
72158 <1% 1,241 $233K
80048 Basic metabolic panel (calcium, ionized) <1% 45,805 $229K
G0330 Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room <1% 202 $225K
J1745 Injection, infliximab, excludes biosimilar, 10 mg <1% 156 $222K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 704 $218K
10060 <1% 1,771 $214K
12001 <1% 1,065 $212K
71250 <1% 3,115 $212K
78431 <1% 253 $211K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 5,260 $211K
77336 <1% 2,601 $210K
20680 <1% 164 $209K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 4,285 $207K
64636 <1% 852 $206K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 1,711 $201K
97165 <1% 1,880 $201K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 3,643 $189K
99203 Doctor's office visit, new patient (routine) <1% 1,321 $188K
94060 <1% 2,961 $187K
49083 <1% 378 $186K
P9045 Infusion, albumin (human), 5%, 250 ml <1% 695 $184K
19083 <1% 220 $183K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 3,080 $180K
20610 <1% 2,174 $171K
76801 <1% 1,831 $168K
P9016 Red blood cells, leukocytes reduced, each unit <1% 577 $162K
99235 <1% 7,928 $160K
70491 <1% 958 $158K
93970 <1% 1,203 $155K
78492 <1% 204 $152K
73221 <1% 735 $152K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 1,069 $146K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 10,472 $145K
97116 <1% 4,233 $144K
58661 <1% 57 $144K
92526 <1% 2,845 $144K
G0378 Hospital observation service, per hour <1% 4,266 $142K
12011 <1% 670 $141K
76819 Fetal biophysical profile; without non-stress testing <1% 1,412 $137K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 78 $136K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 5,709 $132K
97113 <1% 2,326 $127K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 44,733 $124K
93880 <1% 1,287 $118K
93458 <1% 111 $118K
70498 <1% 2,015 $116K
76870 <1% 1,073 $115K
73130 <1% 5,884 $114K
97163 <1% 952 $110K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 107,699 $110K
92610 <1% 1,048 $109K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 835 $107K
73630 <1% 5,946 $106K
77066 Tomosynthesis, mammo <1% 2,556 $106K
72100 <1% 4,576 $103K
77065 Tomosynthesis, mammo <1% 2,662 $101K
71045 Radiologic examination, chest; single view <1% 28,622 $99K
90935 Hemodialysis procedure with single evaluation by a physician <1% 201 $98K
72197 <1% 295 $95K
76641 <1% 784 $91K
97167 <1% 920 $90K
72125 Computed tomography, cervical spine; without contrast material <1% 5,535 $86K
44970 <1% 15 $84K
71271 <1% 815 $81K
94726 <1% 2,144 $77K
73562 <1% 4,440 $76K
12002 <1% 369 $71K
72131 <1% 1,283 $70K
70486 <1% 1,570 $69K
94729 <1% 2,797 $69K
73030 <1% 5,046 $67K
J8597 Antiemetic drug, oral, not otherwise specified <1% 10,190 $65K
80047 <1% 16,033 $65K
83880 <1% 6,974 $65K
99204 Doctor's office visit, new patient (more involved) <1% 447 $62K
70360 <1% 1,157 $62K
58571 <1% 18 $61K
87641 <1% 4,287 $60K
J3490 Unclassified drugs <1% 216,135 $58K
77334 <1% 376 $57K
P9047 Infusion, albumin (human), 25%, 50 ml <1% 118 $55K
97804 <1% 581 $54K
84484 <1% 32,356 $54K
90715 <1% 2,885 $52K
73610 <1% 4,151 $50K
76775 <1% 500 $49K
77300 <1% 740 $49K
76882 <1% 475 $47K
73502 <1% 3,607 $47K
93325 <1% 1,419 $46K
72040 <1% 2,000 $45K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 731 $45K
83036 Hemoglobin; glycosylated (A1C) <1% 10,844 $44K
77063 Screening digital breast tomosynthesis, bilateral <1% 3,034 $41K
47562 <1% 14 $41K
72170 <1% 1,988 $41K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 472 $40K
85610 <1% 24,060 $40K
77470 <1% 58 $39K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 2,508 $39K
77072 <1% 622 $38K
97535 Self-care/home management training, each 15 minutes <1% 1,390 $38K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 13,826 $38K
96375 Therapeutic injection; each additional sequential IV push <1% 34,042 $37K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 4,790 $37K
75561 <1% 102 $36K
72156 <1% 184 $36K
73700 <1% 368 $35K
82962 <1% 40,226 $35K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 5,024 $34K
36415 Collection of venous blood by venipuncture <1% 38,705 $33K
77002 <1% 262 $33K
86850 <1% 13,068 $33K
87040 <1% 4,037 $33K
88307 <1% 2,035 $32K
73564 <1% 2,358 $32K
C1769 Guide wire <1% 5,205 $32K
86923 <1% 1,434 $31K
73110 <1% 2,463 $30K
76604 <1% 960 $28K
93922 <1% 364 $28K
95819 <1% 145 $28K
77338 <1% 70 $27K
87510 <1% 3,150 $27K
76937 <1% 548 $27K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 89 $27K
72110 <1% 1,123 $26K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 17,031 $26K
58558 <1% 14 $24K
86900 <1% 13,632 $24K
76885 <1% 176 $24K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 79 $23K
73560 <1% 1,814 $23K
77062 <1% 1,161 $23K
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies <1% 28 $22K
72146 <1% 290 $22K
73590 <1% 2,333 $21K
86803 <1% 1,961 $20K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 125 $20K
85027 <1% 12,197 $20K
83605 <1% 12,706 $19K
72050 <1% 888 $19K
94660 <1% 94 $19K
76813 <1% 303 $19K
97022 <1% 589 $19K
88342 <1% 4,122 $19K
77061 <1% 751 $18K
95816 <1% 95 $18K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 1,091 $17K
27096 <1% 44 $17K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 11,805 $17K
73140 <1% 943 $17K
80076 <1% 3,991 $16K
82565 <1% 6,065 $16K
77295 <1% 12 $16K
96376 <1% 17,033 $16K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 49,784 $15K
73090 <1% 1,649 $15K
50435 <1% 12 $15K
64450 <1% 89 $15K
93351 <1% 40 $15K
94010 <1% 335 $15K
75574 <1% 58 $15K
96367 <1% 541 $14K
87660 <1% 3,150 $14K
90686 <1% 2,144 $14K
64415 <1% 40 $14K
J1650 Injection, enoxaparin sodium, 10 mg <1% 12,957 $14K
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml <1% 1,586 $14K
64495 <1% 81 $13K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 1,982 $13K
81002 <1% 5,650 $13K
94667 <1% 99 $13K
86901 <1% 13,833 $13K
85379 <1% 2,496 $13K
73080 <1% 1,356 $13K
88341 <1% 2,439 $12K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 53,824 $12K
92611 <1% 222 $12K
74230 <1% 106 $12K
11721 <1% 1,320 $12K
73552 <1% 1,126 $11K
97760 <1% 219 $11K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 2,803 $11K
J2704 Injection, propofol, 10 mg <1% 42,099 $11K
81001 <1% 28,582 $11K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 5,051 $11K
77080 <1% 182 $11K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 4,783 $10K
80061 Lipid panel <1% 2,665 $10K
84443 Thyroid stimulating hormone (TSH) <1% 5,175 $9K
J7120 Ringers lactate infusion, up to 1000 cc <1% 32,964 $9K
64490 <1% 13 $9K
90732 <1% 479 $8K
84145 <1% 800 $8K
J7298 Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg <1% 14 $8K
85014 <1% 16,961 $8K
83735 <1% 16,257 $8K
31575 <1% 62 $8K
99153 Mod sedat endo service >5yrs <1% 2,550 $8K
72157 <1% 71 $8K
64447 <1% 43 $8K
82803 <1% 5,226 $8K
78499 <1% 57 $7K
J7050 Infusion, normal saline solution, 250 cc <1% 24,095 $7K
87632 <1% 405 $7K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 866 $7K
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 152,696 $7K
80179 <1% 1,214 $7K
94618 <1% 54 $7K
36600 <1% 570 $7K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 65 $7K
86140 <1% 9,741 $7K
93798 <1% 48 $7K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring <1% 27 $7K
72070 <1% 428 $7K
74220 <1% 162 $7K
84703 <1% 11,261 $6K
87086 Culture, bacterial; quantitative colony count, urine <1% 10,771 $6K
94727 <1% 202 $6K
78320 <1% 26 $6K
85730 <1% 7,230 $6K
99152 <1% 3,391 $6K
C9399 Unclassified drugs or biologicals <1% 725 $6K
94644 <1% 2,662 $6K
81025 <1% 4,975 $6K
87522 Neg quan hep c or qual rna <1% 267 $6K
82657 <1% 748 $6K
83690 <1% 19,986 $6K
77001 <1% 44 $6K
84702 <1% 4,254 $5K
77085 <1% 87 $5K
77290 <1% 14 $5K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 182 $5K
73100 <1% 297 $5K
J0690 Injection, cefazolin sodium, 500 mg <1% 20,298 $5K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 247 $5K
72082 <1% 93 $5K
72128 <1% 138 $4K
76942 <1% 106 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 18,269 $4K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 30,109 $4K
43762 <1% 31 $4K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 37 $4K
G0008 Administration of influenza virus vaccine <1% 1,586 $4K
97035 <1% 137 $4K
G0379 Direct admission of patient for hospital observation care <1% 12 $4K
93975 <1% 27 $4K
77301 <1% 13 $4K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 219 $4K
87480 <1% 3,140 $4K
82728 <1% 1,429 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 29,895 $4K
74300 <1% 15 $4K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 7,826 $4K
36416 <1% 8,939 $4K
81003 <1% 10,959 $3K
80143 <1% 1,388 $3K
86920 <1% 302 $3K
29125 <1% 96 $3K
74022 <1% 507 $3K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 1,497 $3K
0482T <1% 205 $3K
74240 <1% 25 $3K
C1776 Joint device (implantable) <1% 328 $3K
43760 <1% 13 $3K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 46 $3K
72072 <1% 112 $3K
12013 <1% 13 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 26,741 $3K
80074 <1% 403 $3K
87081 <1% 3,821 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,553 $3K
74019 <1% 221 $3K
74178 <1% 14 $3K
87116 <1% 214 $3K
J7030 Infusion, normal saline solution , 1000 cc <1% 16,170 $3K
73060 <1% 387 $2K
73070 <1% 219 $2K
17250 <1% 14 $2K
85652 <1% 6,879 $2K
72202 <1% 39 $2K
87186 <1% 4,817 $2K
88304 <1% 1,621 $2K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 1,607 $2K
87070 <1% 3,525 $2K
C1729 Catheter, drainage <1% 485 $2K
87075 <1% 2,894 $2K
A4648 Tissue marker, implantable, any type, each <1% 686 $2K
74241 <1% 12 $2K
87077 <1% 4,080 $2K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 7,396 $2K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 1,630 $2K
G0109 Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes <1% 27 $2K
J7999 Compounded drug, not otherwise classified <1% 3,261 $2K
84100 <1% 4,265 $2K
29515 <1% 12 $2K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 7,054 $2K
87205 <1% 3,651 $2K
80164 <1% 265 $2K
J2785 Injection, regadenoson, 0.1 mg <1% 2,157 $2K
96368 <1% 129 $2K
73120 <1% 144 $2K
J1610 Injection, glucagon hydrochloride, per 1 mg <1% 26 $2K
00170 Anesthesia for intraoral procedures, including biopsy <1% 960 $1K
83550 <1% 918 $1K
J8540 Dexamethasone, oral, 0.25 mg <1% 324 $1K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 1,764 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 11,969 $1K
84550 <1% 785 $1K
Q0247 Injection, sotrovimab, 500 mg <1% 21 $1K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 6,388 $1K
A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries <1% 440 $1K
93926 <1% 12 $1K
97542 <1% 14 $1K
51798 <1% 1,124 $1K
J1815 Injection, insulin, per 5 units <1% 4,860 $1K
85045 <1% 841 $1K
A9585 Injection, gadobutrol, 0.1 ml <1% 2,456 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 8,223 $1K
C1874 Stent, coated/covered, with delivery system <1% 32 $1K
J1756 Injection, iron sucrose, 1 mg <1% 187 $1K
94645 <1% 777 $1K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 1,761 $1K
82550 <1% 2,713 $1K
87015 <1% 2,802 $955.66
73200 <1% 13 $952.97
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 248 $935.52
93296 <1% 161 $905.08
99236 Prolong inpt eval add15 m <1% 54 $894.62
83540 <1% 997 $885.11
97014 <1% 27 $881.72
82140 <1% 1,347 $835.89
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 2,556 $831.39
93976 <1% 30 $796.14
85018 <1% 664 $755.71
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 1,653 $739.52
82607 <1% 891 $739.45
83615 <1% 2,047 $738.89
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 7,402 $736.87
82570 <1% 1,728 $721.57
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 5,590 $718.04
J1644 Injection, heparin sodium, per 1000 units <1% 9,193 $701.28
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 510 $678.68
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 8,583 $667.57
89051 <1% 837 $647.91
90694 <1% 140 $641.37
J3370 Injection, vancomycin hcl, 500 mg <1% 3,576 $636.79
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 1,368 $632.13
85046 <1% 361 $616.69
87088 <1% 1,430 $594.33
J3535 Drug administered through a metered dose inhaler <1% 3,144 $534.83
73522 <1% 14 $524.27
J3475 Injection, magnesium sulfate, per 500 mg <1% 3,515 $509.83
J1030 Injection, methylprednisolone acetate, 40 mg <1% 2,429 $501.87
C1893 Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away <1% 32 $495.60
A9270 Non-covered item or service <1% 4,178 $494.59
82330 <1% 357 $492.44
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 1,871 $472.19
78434 <1% 252 $466.42
J0780 Injection, prochlorperazine, up to 10 mg <1% 3,862 $458.46
90656 <1% 52 $443.41
J1790 Injection, droperidol, up to 5 mg <1% 4,459 $441.23
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 4,307 $439.80
J2060 Injection, lorazepam, 2 mg <1% 3,566 $397.37
J3480 Injection, potassium chloride, per 2 meq <1% 2,941 $384.66
A6198 Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 48 sq. in., each dressing <1% 252 $368.50
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 831 $366.84
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 4,237 $361.12
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 3,942 $359.28
82746 <1% 546 $356.84
93226 <1% 13 $355.85
88313 <1% 211 $338.40
84156 <1% 1,053 $327.68
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,397 $321.84
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 1,535 $320.91
88360 <1% 60 $278.88
90653 <1% 86 $266.69
0004A <1% 13 $254.10
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) <1% 174 $249.72
G0257 Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility <1% 28 $243.69
87340 <1% 664 $241.07
J1626 Injection, granisetron hydrochloride, 100 mcg <1% 1,296 $237.70
J2550 Injection, promethazine hcl, up to 50 mg <1% 2,232 $225.02
86706 <1% 530 $224.37
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 10,332 $221.77
S0028 Injection, famotidine, 20 mg <1% 3,063 $220.32
84439 <1% 288 $216.31
J1940 Injection, furosemide, up to 20 mg <1% 2,275 $211.89
S0164 Injection, pantoprazole sodium, 40 mg <1% 2,206 $210.01
88112 <1% 27 $206.64
J2310 Injection, naloxone hydrochloride, per 1 mg <1% 413 $186.05
88312 <1% 58 $176.16
J1040 Injection, methylprednisolone acetate, 80 mg <1% 906 $164.12
89050 <1% 101 $162.61
43450 <1% 45 $151.29
L0120 Cervical, flexible, non-adjustable, prefabricated, off-the-shelf (foam collar) <1% 1,080 $145.29
J1580 Injection, garamycin, gentamicin, up to 80 mg <1% 1,347 $137.09
51701 <1% 108 $120.47
90662 <1% 33 $118.30
87206 <1% 344 $117.62
86592 <1% 205 $114.26
Q0169 Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 952 $111.49
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 1,647 $100.57
93225 <1% 14 $99.74
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 458 $99.16
J3360 Injection, diazepam, up to 5 mg <1% 486 $98.45
80069 <1% 44 $97.48
G0009 Administration of pneumococcal vaccine <1% 299 $96.25
64615 <1% 29 $96.24
J7042 5% dextrose/normal saline (500 ml = 1 unit) <1% 763 $94.09
G0475 Hiv antigen/antibody, combination assay, screening <1% 24 $93.71
82272 <1% 871 $91.47
J0360 Injection, hydralazine hcl, up to 20 mg <1% 1,204 $90.18
J3372 Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg <1% 203 $85.53
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 368 $83.41
J3486 Injection, ziprasidone mesylate, 10 mg <1% 16 $82.68
87807 <1% 188 $79.87
87071 <1% 124 $75.25
87102 <1% 230 $73.53
J3411 Injection, thiamine hcl, 100 mg <1% 1,059 $73.22
87899 <1% 125 $71.21
82150 <1% 141 $70.41
80178 <1% 12 $68.72
80050 General health panel <1% 89 $67.05
93356 <1% 42 $64.49
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml <1% 2,341 $64.44
82784 <1% 53 $63.99
85384 <1% 162 $63.92
J2470 Injection, pantoprazole sodium, 40 mg <1% 233 $63.70
87046 <1% 105 $62.59
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg <1% 29 $60.51
A6197 Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing <1% 637 $51.48
J0692 Injection, cefepime hydrochloride, 500 mg <1% 474 $47.51
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 1,990 $46.04
J1630 Injection, haloperidol, up to 5 mg <1% 385 $45.63
87045 <1% 96 $44.61
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 1,612 $41.34
87449 <1% 88 $40.06
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 788 $40.02
S0077 Injection, clindamycin phosphate, 300 mg <1% 1,324 $38.26
84132 <1% 145 $35.14
87147 <1% 106 $33.96
88302 <1% 32 $32.12
82010 <1% 163 $31.50
J1010 Injection, methylprednisolone acetate, 1 mg <1% 225 $27.55
A6210 Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing <1% 815 $24.47
J0737 Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg <1% 123 $19.58
J7060 5% dextrose/water (500 ml = 1 unit) <1% 324 $18.81
88311 <1% 13 $17.41
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 17 $14.97
93321 <1% 320 $11.81
J1836 Injection, metronidazole, 10 mg <1% 562 $8.48
94761 <1% 310 $7.69
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 1,000 $6.82
85347 <1% 25 $5.67
82945 <1% 29 $5.51
C9113 Injection, pantoprazole sodium, per vial <1% 62 $5.24
86308 <1% 77 $4.66
J1920 Injection, labetalol hydrochloride, 5 mg <1% 151 $4.07
J1596 Injection, glycopyrrolate, 0.1 mg <1% 182 $2.97
84157 <1% 72 $2.85
S0030 Injection, metronidazole, 500 mg <1% 1,019 $2.27
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 623 $0.01
A4649 Surgical supply; miscellaneous 0% 2,123 $0.00
A6196 Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing 0% 41 $0.00
87324 0% 32 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 57 $0.00
51702 0% 45 $0.00
99157 0% 34 $0.00
J1953 Injection, levetiracetam, 10 mg 0% 377 $0.00
22853 0% 28 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 118 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 540 $0.00
A6021 Collagen dressing, sterile, size 16 sq. in. or less, each 0% 671 $0.00
20930 0% 67 $0.00
Q9961 High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml 0% 68 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 0% 132 $0.00
A9526 Nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuries 0% 91 $0.00
J0736 Injection, clindamycin phosphate, 300 mg 0% 60 $0.00
J3260 Injection, tobramycin sulfate, up to 80 mg 0% 23 $0.00
C1758 Catheter, ureteral 0% 31 $0.00
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring 0% 34 $0.00
J9370 Vincristine sulfate, 1 mg 0% 57 $0.00
70250 0% 13 $0.00
J2359 Injection, olanzapine, 0.5 mg 0% 34 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 158 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 0% 209 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 160 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 175 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 158 $0.00
J2358 Injection, olanzapine, long-acting, 1 mg 0% 227 $0.00
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries 0% 107 $0.00
99156 0% 206 $0.00
C1781 Mesh (implantable) 0% 127 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 0% 171 $0.00
G8982 Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 14 $0.00
96409 0% 85 $0.00
J3590 Unclassified biologics 0% 68 $0.00
J9045 Injection, carboplatin, 50 mg 0% 25 $0.00
J2305 Injection, nitroglycerin, 5 mg 0% 12 $0.00
G0269 Placement of occlusive device into either a venous or arterial access site, post surgical or interventional procedure (e.g., angioseal plug, vascular plug) 0% 12 $0.00
88300 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPRESCOTT, ELEANOR (GOVERNMENT PROGRAM MANAGER)
Same official

Other billing entities under PRESCOTT, ELEANOR

Full network →
ProviderLocationPaid
Carilion Medical CenterRoanoke, VA$73.43M
Carilion Healthcare CorporationRoanoke, VA$26.07M
Carilion Medical CenterRoanoke, VA$18.08M
Carilion Rockbridge Community HospitalLexington, VA$11.82M
Carilion Emergency Services, INC.Roanoke, VA$11.09M
Carilion Giles Community HospitalPearisburg, VA$10.32M
Carilion Tazewell Community HospitalTazewell, VA$8.03M
Carilion Medical CenterRoanoke, VA$7.31M
Carilion Giles Community HospitalPearisburg, VA$2.40M
Carilion Giles Community HospitalMartinsville, VA$1.99M
Carilion Giles Community HospitalGalax, VA$1.67M
Carilion Giles Community HospitalRocky Mount, VA$1.14M
Carilion Giles Community HospitalWytheville, VA$880K
Carilion Giles Community HospitalFloyd, VA$697K
Carilion Tazewell Community HospitalTazewell, VA$677K
Carilion Giles Community HospitalTazewell, VA$379K
Carilion Giles Community HospitalHillsville, VA$354K
Carilion Rockbridge Community HospitalBuchanan, VA$322K
Carilion Giles Community HospitalPearisburg, VA$254K
Carilion Rockbridge Community HospitalBedford, VA$241K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.